Sonova Holding AG, CH0012549785

Barclays keeps Sell rating on Sonova stock

Published on 10/01/2026 at 16:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2025/26 sales rose 5.9 percent in local currencies. Sonova stock costs EUR 266.15 on October 1, 2026 versus EUR 264.35.

A Bauhaus style graphic design poster featuring a stylized geometric human ear rendered as concentric arcs and angular lines on the left, with bold concentric sound wave rings radiating outward to the right, composed on a geometric grid using primary colo
Sonova CH0012549785: Bauhaus-Grafikposter mit geometrischem Ohr, konzentrischen Schallwellen und Primärfarben auf weißem Grund, Illustration mit AI erstellt.

Sonova stock (ISIN CH0012549785) was trading at EUR 266.15 at Lang & Schwarz on October 1, 2026, at 4:07 p.m. CEST. On September 24, 2026, Barclays analyst Hassan Al-Wakeel maintained a Sell rating and set a CHF 175.00 price target for Sonova, as Markets Insider reported.

Barclays target trails the market view

The CHF 175.00 target stands CHF 55.60 below the CHF 230.60 average target cited in the same September 24 report. That spread gives the rating a clear counterweight to the companys operating progress, although the two figures reflect different analyst views rather than a company forecast.

Sonova also entered October with a recent product and innovation narrative. The companys investor page says its Phonak EON hearing aid portfolio launched on August 24, 2026, with a new chip, artificial intelligence features and Made-For-All connectivity, according to Sonova.

Sales growth supports the product push

In fiscal 2025/26, group sales reached CHF 3,605.9 million, up 5.9 percent in local currencies, while net profit reached CHF 546 million, the company said in its September 29 release carried by Financial Times. Sonova ranked first among the 100 large companies in the latest Swiss innovation ranking, with the release highlighting speech extraction from background noise and the EON portfolio.

Managements outlook for fiscal 2026/27 calls for consolidated sales growth of 5 percent to 8 percent and core EBIT growth of 7 percent to 10 percent at constant exchange rates, according to the companys May 18, 2026 earnings-call transcript published by Yahoo Finance. The upcoming second-quarter fiscal 2026/27 results are scheduled for November 12, 2026, according to MarketScreener.

Euro quote stays above prior close

At 4:07 p.m. CEST on October 1, 2026, Sonova was trading at EUR 266.15 at Lang & Schwarz, up 0.68 percent versus the prior close of EUR 264.35 on September 30, 2026. The modest daily gain leaves the analyst disagreement and the execution of the EON product cycle as the main valuation reference points.

The further course of trading is shown by the continuously updated real-time quote of Sonova stock.

Sonova stock at a glance

  • Company: Sonova Holding AG
  • ISIN: CH0012549785
  • Ticker: SOON
  • Primary exchange: SIX Swiss Exchange
  • Price Lang & Schwarz as of October 1, 2026, 4:07 p.m. CEST: EUR 266.15
  • Change versus prior close: plus 0.68 percent
  • Prior close Lang & Schwarz September 30, 2026: EUR 264.35
  • Sector / Industry: Healthcare / Medical Devices
  • Next earnings date: November 12, 2026

More news and analyses on Sonova stock

Disclaimer...

en | CH0012549785 | SONOVA HOLDING AG | boerse | 70211173 | bgmi